Updated:
HealthCor Catalio Acquisition Corp.
HealthCor Catalio Acquisition Corp. was formed as a special purpose acquisition company (SPAC) in 2021, with origins tied to HealthCor Management and...
HealthCor Catalio Acquisition Corp.
HealthCor Catalio Acquisition Corp. was formed as a special purpose acquisition company (SPAC) in 2021, with origins tied to HealthCor Management and Catalio Capital Management. The SPAC was created to identify a target in healthcare, biotech, or life sciences, combining the operational expertise of HealthCor's investment team with Catalio's scientific and venture capital network. The strategy is to acquire a single company through a merger, providing growth capital and public market access. The firm focuses on companies with proven technology or clinical data, targeting sectors such as biotech, medical devices, and diagnostics. The geographic footprint is primarily North America, with potential expansions into Europe. The SPAC structure limits deployment to one transaction, with a trust of roughly $200 million from its initial public offering (per SEC filings, 2021). As of 2023, HealthCor Catalio Acquisition Corp. had not completed a merger, remaining in search mode. The firm maintains offices in St. Petersburg, Dallas, Greenwich, and New York. It has not disclosed a team size or additional vehicles. A dated event from the last 24 months includes the firm's ongoing search for a target, as no definitive agreement was reached by mid-2024 (per public record). The structural differentiator is the SPAC framework itself: a blank-check company with a predefined 24-month window to complete an acquisition, after which it must return capital to shareholders. This time-bound mandate distinguishes it from traditional family offices or venture firms, adding a forced-resolution timeline to its investment posture.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
St. Petersburg
Corporate office
St. Petersburg, FL, United States
Additional offices
Dallas, TX, United States · Greenwich, CT, United States · New York, NY, United States
Sector focus
Frequently asked questions
Who sponsors HealthCor Catalio Acquisition Corp.?
The SPAC is sponsored by HealthCor Management and Catalio Capital Management. HealthCor Management is a healthcare-focused investment manager, while Catalio Capital Management is a life sciences venture firm. Both contribute domain expertise and deal flow to the SPAC target search.
What is the investment mandate of this SPAC?
HealthCor Catalio Acquisition Corp. targets a merger with a private company in the healthcare, biotech, or life sciences sector. It focuses on growth-stage companies with validated technology or clinical data, aiming to provide public market access via a de-SPAC transaction.
Has HealthCor Catalio Acquisition Corp. completed a merger?
As of mid-2024, the SPAC had not announced a definitive merger agreement. It remains in search of a suitable target within its 24-month window, per public filings.
What is the trust size of the SPAC?
The SPAC raised approximately $200 million in its initial public offering (per SEC filings, 2021). This capital is held in trust until a merger is completed or the SPAC is liquidated.
How is this SPAC different from a typical family office?
Unlike a traditional family office that makes ongoing investments, a SPAC is a one-time vehicle with a single acquisition mandate. The structure forces a time-bound decision, after which capital must be returned if no deal closes.
What happens if the SPAC doesn't find a target?
If no merger is completed within the specified timeframe (typically 24 months), the SPAC must liquidate and return the trust capital to shareholders. This adds a forced-resolution element not present in standard family offices.
Which sectors does HealthCor Catalio Acquisition Corp. explicitly avoid?
The SPAC's mandate is narrowly focused on healthcare and life sciences. It does not target sectors outside these areas, such as technology, energy, or consumer goods.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: